![The Asian Pacific Association for the Study of the Liver [APASL]](https://www.apasl.info/wp-apasl/wp-content/themes/apasl/images/header/img_apasl_logo.png){kind=logo}
| Year | City | President | Topic | APASL Designated Conference |
|---|---|---|---|---|
| 2006 (1st) | Calcutta | Dr. YK Chawla | Hepatic Fibrosis-Basic Science to Therapy | — |
| 2007 (2nd) | Pattaya | Dr. C Pramoolsinsap | The Innovation in Chronic Hepatitis B Treatment | 1st APASL HBV Conference |
| 2008 (3rd) | Cairo | Dr. G Shiha Dr. A Ibrahim |
Liver Fibrosis | 1st APASL Liver Fibrosis Conference |
| 2008 (4th) | Bali | Dr. L Lesmana | Hepatocellular Carcinoma | 1st APASL HCC Conference |
| 2009 (5th) | Istanbul | Dr. AK Dökmeci | Non Responders | — |
| 2009 (6th) | Karachi | Dr. S Hamid Dr. W Jafri |
Acute Liver Failure : Asian-Pacfic Perspectives | 1st APASL ACLF Conference |
| 2010 (7th) | Chiba | Dr. O Yokosuka | HCV | 1st APASL HCV Conference |
| 2011 (8th) | Beijing | Dr. FS Wang | Hepatitis B Virus | 2nd APASL HBV Conference |
| 2011 (9th) | Jeju | Dr. BC Yoo | Hepatocellular Carcinoma | 2nd APASL HCC Conference |
| 2012 (10th) | Ulaan baatar | Dr. A Jazag | HBV & HCV Dual Infection | 2nd APASL HCV Conference |
| 2012 (11th) | Dhaka | Dr. S Rahman | HBV | 3rd APASL HBV Conference |
| 2013 (12th) | Cebu | Dr. D Payawal | HCC | 3rd APASL HCC Conference |
| 2013 (13th) | Jakarta | Dr. R Gani | NASH | 1st APASL NASH Conference |
| 2014 (14th) | Cairo | Dr. G Shiha | Liver Fibrosis | 2nd APASL Liver Fibrosis Conference |
| 2014 (15th) | Karachi | Dr. Z Abbas | HCV | 3rd APASL HCV Conference |
| 2014 (16th) | Guangzhou | Dr. JL Hou | HBV | 4th APASL HBV Conference |
| 2015 (17th) | Yerevan | Dr. H Ghazinyan | HBV | 5th APASL HBV Conference |
| 2015 (18th) | New Delhi | Dr. BC Sharma | HCV | 4th APASL HCV Conference |
| 2016 (19th) | Busan | Dr. KH Han | Liver Cirrhosis | 1st APASL Liver Cirrhosis Conference |
| 2016 (20th) | Kaohsiung | Dr. WL Chuang | HCV | 5th APASL HCV Conference |
| 2016 (21st) | Beijing | Dr. Lai Wei | HBV | 6th APASL HBV Conference |
| 2017 (22nd) | Nagasaki | Dr. Hiroshi Yatsuhashi | HCC | 4th APASL HCC Conference |
| 2017 (23rd) | Ulaanbaatar | Dr. Oidov Baatarkhuu | HCV and coinfection | 6th APASL HCV Conference |
| 2017 (24th) | Cairo | Dr. Gamal Shiha | HCV | 7th APASL HCV Conference |
| 2018 (25th) | Yokohama | Dr. Shuichiro Shiina | HCC | 5th APASL HCC Conference |
| 2018 (26th) | Taipei | Dr. Rong-Nan Chien | HBV in Asia-Pacific | 7th APASL HBV Conference |
| 2018 (27th) | Kuala Lumpur | Dr. Rosmawati Mohamed | HCV | 8th APASL HCV Conference |
| 2018 (28th) | Istanbul | Dr. Necati Ormeci | Non-Responder | — |
| 2018 (29th) | Beijing | Dr. Gui-Qiang Wang | Autoimmune | — |
| 2019 (30th) | Tokyo | Dr. Atsushi Tanaka | Liver Immunology and Genetics | — |
| 2019 (31st) | Baku | Dr. Gulnara Aghayeva | Hepatitis Delta | — |
| 2020 (32nd) | Guangzhou | Dr. Xiaolong Qi | Portal Hypertension | — |
| 2021 (33rd) | Osaka | Dr. Norifumi Kawada | Molecular and Cellular Biology | — |
| 2021 (34th) | Tokyo | Dr. Mitsuhiko Moriyama | Oncology | 1st APASL 2020 Oncology 6th APASL HCC Conference |
| 2022 (35th) | Beijing | Dr. Hong You | Liver Fibrosis | — |
| 2022 (36th) | Taipei | Dr. Chun-Jen Liu | Paradigm Shift of HCC Management: Across Viral to Steatogenic Carcinogenesis | — |
| 2022 (37th) | Cairo | Dr. Gamal Shiha | Liver Fibrosis: Liver Fibrosis in the era of MAFLD | — |
| 2022 (38th) | Takamatsu | Dr. Tsutomu Masaki | HCC：Clinical and basic research | — |
| 2022 (39th) | Wuhan | Dr. Qin Ning | Critical Care in Hepatology ACLF | — |
| 2022 (40th) | Istanbul | Dr. Ibrahim Halil Bahcecioglu | Hepatotoxicity | — |
| 2022 (41st) | Yerevan | Dr. Hasmik Ghazinian | NAFLD/NASH: Non-Infection Epidemic in XXI | — |
| 2022 (42nd) | Guangzhou | Dr. Jinjun Chen | Image-guided Interventions in Liver Diseases | — |
| 2023 (43rd) | Manila | Dr. Ian Homer Y. Cua | Liver Cirrhosis and Its Complication | — |
| 2023 (44th) | Busan | Dr. Si Hyun Bae | Viral Hepatitis | — |
| 2023 (45th) | Sendai | Dr. Yoshiyuki Ueno | Oncology | — |
| 2024 (46th) | Kaohsiung | Dr. Ming Lung Yu | Metabolic Disorders | — |
| 2024 (47th) | Chiba | Dr. Naoya Kato | Genomics Meets Immunology | — |
| 2024(48th) | Bali | Dr. Cosmas Rinaldi A. Lesmana | New Concept of Portal Hypertension and Hepatobiliary Malignancy related | — |
| 2024 (49th) | Almaty | Dr. Alexander Nersesov | Liver Cirrhosis: Common and Rare Complications | |
| 2025 (50th) | Mumbai | Dr. Akash Shukla | Improving Non-transplant Outcomes in Patients with Advanced Liver Disease | |
| 2025 (51st) | Istanbul | Dr. Vedat Goral | Liver Cirrhosis: Current and New Therapies | |
| 2025 (52nd) | Qingdao | Dr. Jinzhen Cai | Full Process Management of Liver Transplant Patients | |
| 2025 (53rd) | Tashkent | Dr. Musabaev Erkin | Viral Hepatitis Elimination by 2030: Progress and Challenges | |
| 2025 (54th) | Taipei | Dr. Yi-Hsiang Huang | Oncology-Multifaceted Approach and Treatment for Liver Cancer | |
| 2025 (55th) | Moscow | Dr. Andrey Kostin | Alcoholic Liver Disease | 3rd APASL NASH Conference |
| 2025 (56th) | Tokyo | Dr. Kenichi Ikejima | New Horizons for Steatotic Liver Disease: Cutting Edge Research and Emerging Therapeutics | 4th APASL NASH Conference |
| 2025 (57th) | Yangon | Dr. Kyaw Soe Tun | Current Management of HCC with Local Relevance | 11th APASL HCC Conference |
| 2025 (58th) | Karachi | Dr. Amna Subhaan Butt | MAFLD and Metabolic Complications: Applying Multidisciplinary Solutions | 5th APASL NASH Conference |